Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
  • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
  • A61K51/04—Organic compounds
  • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
  • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
  • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
  • C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
  • C07C275/16—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
  • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
  • A61K51/04—Organic compounds
  • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
  • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
  • A61K51/04—Organic compounds
  • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P13/00—Drugs for disorders of the urinary system
  • A61P13/08—Drugs for disorders of the urinary system of the prostate
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
  • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
  • C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
  • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
  • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
  • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
• • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
  • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
  • Y02P20/00—Technologies relating to chemical industry
  • Y02P20/50—Improvements relating to the production of bulk chemicals
  • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Optics & Photonics (AREA)
• Epidemiology (AREA)
• Physics & Mathematics (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Urology & Nephrology (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
• Plural Heterocyclic Compounds (AREA)
• Peptides Or Proteins (AREA)
• Medicinal Preparation (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=59899817

Family Applications (2)

Family Applications After (1)

Country Status (27)

Families Citing this family (32)

Family Cites Families (14)

• 2017
  • 2017-03-22 ES ES17771028T patent/ES2877572T3/es active Active
  • 2017-03-22 EP EP17771028.2A patent/EP3433238B1/en active Active
  • 2017-03-22 DK DK21177643.0T patent/DK3925952T3/da active
  • 2017-03-22 HU HUE17771028A patent/HUE055607T2/hu unknown
  • 2017-03-22 RU RU2021115958A patent/RU2021115958A/ru unknown
  • 2017-03-22 TR TR2018/13644A patent/TR201813644T1/tr unknown
  • 2017-03-22 CN CN202510305793.6A patent/CN120172884A/zh active Pending
  • 2017-03-22 LT LTEPPCT/US2017/023508T patent/LT3433238T/lt unknown
  • 2017-03-22 EP EP24153551.7A patent/EP4385981A1/en active Pending
  • 2017-03-22 ES ES21177643T patent/ES2972148T3/es active Active
  • 2017-03-22 PL PL21177643.0T patent/PL3925952T3/pl unknown
  • 2017-03-22 JP JP2018549808A patent/JP7073270B2/ja active Active
  • 2017-03-22 KR KR1020237034341A patent/KR20230147751A/ko not_active Ceased
  • 2017-03-22 AU AU2017238181A patent/AU2017238181B2/en active Active
  • 2017-03-22 KR KR1020187030310A patent/KR102396307B1/ko active Active
  • 2017-03-22 MX MX2018011519A patent/MX384823B/es unknown
  • 2017-03-22 PL PL17771028T patent/PL3433238T3/pl unknown
  • 2017-03-22 RS RS20240205A patent/RS65188B1/sr unknown
  • 2017-03-22 SI SI201730908T patent/SI3433238T1/sl unknown
  • 2017-03-22 RU RU2018133693A patent/RU2749399C2/ru active
  • 2017-03-22 DK DK17771028.2T patent/DK3433238T3/da active
  • 2017-03-22 HU HUE21177643A patent/HUE065327T2/hu unknown
  • 2017-03-22 US US16/087,395 patent/US11458213B2/en active Active
  • 2017-03-22 KR KR1020227015010A patent/KR20220063298A/ko not_active Ceased
  • 2017-03-22 PT PT211776430T patent/PT3925952T/pt unknown
  • 2017-03-22 HR HRP20240215TT patent/HRP20240215T1/hr unknown
  • 2017-03-22 BR BR112018069507A patent/BR112018069507A2/pt unknown
  • 2017-03-22 CA CA3018709A patent/CA3018709A1/en active Pending
  • 2017-03-22 CN CN202210306552.XA patent/CN114716387B/zh active Active
  • 2017-03-22 FI FIEP21177643.0T patent/FI3925952T3/fi active
  • 2017-03-22 PT PT177710282T patent/PT3433238T/pt unknown
  • 2017-03-22 RS RS20211071A patent/RS62274B1/sr unknown
  • 2017-03-22 KR KR1020257012794A patent/KR20250057132A/ko active Pending
  • 2017-03-22 LT LTEP21177643.0T patent/LT3925952T/lt unknown
  • 2017-03-22 CN CN201780031580.2A patent/CN109311827B/zh active Active
  • 2017-03-22 WO PCT/US2017/023508 patent/WO2017165473A1/en not_active Ceased
  • 2017-03-22 HR HRP20211386TT patent/HRP20211386T1/hr unknown
  • 2017-03-22 SI SI201731477T patent/SI3925952T1/sl unknown
  • 2017-03-22 EP EP21177643.0A patent/EP3925952B1/en active Active
• 2018
  • 2018-09-21 CL CL2018002683A patent/CL2018002683A1/es unknown
  • 2018-09-24 PH PH12018502048A patent/PH12018502048A1/en unknown
  • 2018-09-25 ZA ZA2018/06389A patent/ZA201806389B/en unknown
  • 2018-09-25 SA SA518400103A patent/SA518400103B1/ar unknown
• 2021
  • 2021-09-13 CY CY20211100803T patent/CY1124487T1/el unknown
• 2022
  • 2022-05-11 JP JP2022077992A patent/JP2022116028A/ja active Pending
  • 2022-08-22 US US17/892,203 patent/US20230015736A1/en not_active Abandoned
• 2024
  • 2024-01-11 JP JP2024002743A patent/JP2024050608A/ja active Pending
  • 2024-12-13 US US18/979,841 patent/US20250195700A1/en active Pending

Also Published As

Similar Documents